These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24622073)

  • 1. Diagnosis of pernicious anemia and the risk of pancreatic cancer.
    Shah P; Rhim AD; Haynes K; Hwang WT; Yang YX
    Pancreas; 2014 Apr; 43(3):422-6. PubMed ID: 24622073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study.
    Almario CV; Metz DC; Haynes K; Yang YX
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1259-64. PubMed ID: 26225868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pernicious anemia and colorectal cancer risk - A nested case-control study.
    Boursi B; Mamtani R; Haynes K; Yang YX
    Dig Liver Dis; 2016 Nov; 48(11):1386-1390. PubMed ID: 27481584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hip fracture risk in patients with a diagnosis of pernicious anemia.
    Merriman NA; Putt ME; Metz DC; Yang YX
    Gastroenterology; 2010 Apr; 138(4):1330-7. PubMed ID: 20026065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Light at Night and Risk of Pancreatic Cancer in the NIH-AARP Diet and Health Study.
    Xiao Q; Jones RR; James P; Stolzenberg-Solomon RZ
    Cancer Res; 2021 Mar; 81(6):1616-1622. PubMed ID: 33514513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of pancreatic adenocarcinoma.
    Simoes PK; Olson SH; Saldia A; Kurtz RC
    Chin Clin Oncol; 2017 Jun; 6(3):24. PubMed ID: 28705001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer of the upper gastrointestinal tract among patients with pernicious anemia: a case-cohort study.
    Karlson BM; Ekbom A; Wacholder S; McLaughlin JK; Hsing AW
    Scand J Gastroenterol; 2000 Aug; 35(8):847-51. PubMed ID: 10994624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term Risk of Malignancy in Branch-Duct Intraductal Papillary Mucinous Neoplasms.
    Oyama H; Tada M; Takagi K; Tateishi K; Hamada T; Nakai Y; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Morishita Y; Arita J; Hasegawa K; Tanaka M; Fukayama M; Koike K
    Gastroenterology; 2020 Jan; 158(1):226-237.e5. PubMed ID: 31473224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Types of fish consumed and fish preparation methods in relation to pancreatic cancer incidence: the VITAL Cohort Study.
    He K; Xun P; Brasky TM; Gammon MD; Stevens J; White E
    Am J Epidemiol; 2013 Jan; 177(2):152-60. PubMed ID: 23221729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes.
    Tseng CH
    Eur J Clin Invest; 2016 Jan; 46(1):70-9. PubMed ID: 26584246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Risk After Pernicious Anemia in the US Elderly Population.
    Murphy G; Dawsey SM; Engels EA; Ricker W; Parsons R; Etemadi A; Lin SW; Abnet CC; Freedman ND
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2282-9.e1-4. PubMed ID: 26079040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin use is associated with pancreatic cancer risk but does not affect survival.
    Boursi B; Huber JS; Haynes K; Mamtani R; Yang YX
    Cancer Causes Control; 2021 Jan; 32(1):41-46. PubMed ID: 33064241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin use and pancreatic cancer risk in two prospective cohort studies.
    Hamada T; Khalaf N; Yuan C; Babic A; Morales-Oyarvide V; Qian ZR; Nowak JA; Ng K; Kraft P; Rubinson DA; Stampfer MJ; Giovannucci EL; Fuchs CS; Ogino S; Wolpin BM
    J Gastroenterol; 2018 Aug; 53(8):959-966. PubMed ID: 29362938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
    Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC; Paterson JM; Ernst P;
    BMJ; 2016 Feb; 352():i581. PubMed ID: 26888382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
    Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
    BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
    Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
    Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating Physical Activity in the Etiology of Pancreatic Cancer: The Age at Which This Is Measured Is Important and Is Independent of Body Mass Index.
    Noor NM; Banim PJ; Luben RN; Khaw KT; Hart AR
    Pancreas; 2016 Mar; 45(3):388-93. PubMed ID: 26390426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
    Yopp AC; Katabi N; Janakos M; Klimstra DS; D'Angelica MI; DeMatteo RP; Fong Y; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg; 2011 May; 253(5):968-74. PubMed ID: 21422912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and predictive risk factors for intraductal papillary mucinous neoplasm of the pancreas with ordinary pancreatic cancer.
    Okabayashi T; Nishimori I; Maeda H; Hanazaki K
    J Clin Gastroenterol; 2010 Jan; 44(1):75-6. PubMed ID: 19564793
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
    Canto MI; Almario JA; Schulick RD; Yeo CJ; Klein A; Blackford A; Shin EJ; Sanyal A; Yenokyan G; Lennon AM; Kamel IR; Fishman EK; Wolfgang C; Weiss M; Hruban RH; Goggins M
    Gastroenterology; 2018 Sep; 155(3):740-751.e2. PubMed ID: 29803839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.